Oxford university spinout OrganOx sold to Japanese group Terumo for $1.5bn
Co-founder says sale to medtech company will accelerate global adoption of its transplantation technology
Related reading
Amgen swoops on UK cancer biotech in deal worth up to $840mn
Dark Blue Therapeutics was spun out of an Oxford university incubator in 2022
Thermo Fisher aims to sell parts of its diagnostics business for $4bn
Deal would mark latest move by a life sciences group to jettison lower-growth assets
EQT in talks to take over Oxford BioMedica
Buyout of UK-listed group would be latest private equity deal for a European public company
SoftBank’s bet on OpenAI is starting to weigh
Japanese group has suffered from recent share falls and a negative outlook from rating agency S&P
TPG and Blackstone near deal for medical technology company Hologic
Acquisition by private equity groups would be one of the biggest take-private deals of the year
UK biotech keeps selling itself to America
A shortage of late-stage capital pushes the biggest prizes into US hands